General Overview
iCHOR is a thrombectomy platform designed to remove thrombus from blood vessels using a balloon sweep mechanism combined with a nitinol capture basket.
iCHOR uses a Fogarty-style balloon to mobilize thrombus, sweeping it into a nitinol basket where it is captured and removed from the body in a controlled manner.
iCHOR is used for the removal of thrombus in peripheral vascular procedures, including arterial, venous and dialysis access (AV fistulas and grafts).
Vascular surgeons, interventional radiologists, and interventional cardiologists performing thrombectomy procedures.
Clinical Benefits
Unlike aspiration systems that rely on suction, iCHOR mechanically mobilizes and captures thrombus, reducing reliance on large-bore catheters and external aspiration systems.
iCHOR uses a controlled sweep-and-capture approach, minimizing vessel wall interaction and reducing the risk of endothelial trauma compared to more aggressive mechanical devices.
No. iCHOR is designed as an all-in-one solution, reducing the need for multiple catheter exchanges or adjunctive devices.
Yes. It can be used as a standalone treatment, adjunctive therapy or bailout option depending on the clinical scenario.
iCHOR technology directly addresses the operational pressures healthcare systems face today by embedding simplicity into every aspect of the procedure.
Reduced staffing requirements: iCHOR eliminates capital equipment entirely, no consoles, no clinical service reps to operate machines, no biomedical engineering for preventative maintenance. Physicians report completing procedures with a fraction of the typical staff because there are fewer components to manage.
Streamlined supply chain: Fewer SKUs treat more patients, easing inventory complexity and reducing the supply chain burden that strains procurement teams.
Expanded capacity: iCHOR’s simplicity enables procedures to move from hospital settings to ambulatory surgical centers and office-based labs. This shifts volume away from overburdened hospital departments, creates capacity for critical cases, frees up ICU beds, and now allows many patients to go home the same day.
Seamless workflow: The platform removes vascular obstructions while transitioning directly to treat underlying lesions with proven angioplasty and stenting solutions as one integrated workflow rather than multiple device handoffs.
The result: more patients treated with fewer resources, faster throughput, and reduced burden on overworked clinical teams.
iCHOR is designed for durable results in acute, organized, and embolic vascular occlusions, whether in deep vein thrombosis or thrombosed peripheral arteries.
Safe, effective revascularization: iCHOR restores flow without the risks of blood loss or vessel damage that can compromise healing and long-term patency.
Synergy with definitive treatment: The platform works in concert with balloon angioplasty and stenting, not only optimizing immediate results but also serving as an ongoing stent management solution to maintain long-term patency.
Right tool for the right condition: iCHOR is purpose-built for what it does best. iCHOR will restore flow by removing acute, organized or embolic occlusions, however chronic venous disease is better served by proven venous stenting; and calcified arterial lesions by atherectomy / stenting. This focused indication means patients receive the most appropriate intervention which itself supports better outcomes.
Workflow designed around the patient: The system’s packaging and procedural simplicity aren’t just operational benefits, they enable same-day discharge and reduce the burden of hospitalization, contributing to faster recovery and better patient experience.
Procedure and Workflow
The procedure is straightforward and familiar to physicians who are experienced with balloon embolectomy techniques.
No. ICHOR is a disposable system and does not require capital equipment such as aspiration pumps.
iCHOR is available in multiple sizes, including smaller profile systems (7F) and larger systems (14F), depending on the target vessel and thrombus burden.
Yes. iCHOR is designed to be compatible with standard guidewires commonly used in vascular procedures.
Safety and Performance
The nitinol basket captures thrombus during the sweep, helping to contain clot and reduce the risk of embolization.
iCHOR leverages a well-established balloon embolectomy principle, which has a long history of safe use when performed appropriately.
The balloon embolectomy technique has decades of clinical validation, and iCHOR builds on this foundation with modern enhancements for endovascular use.
Economic Value
iCHOR is designed to reduce overall procedural costs by eliminating the need for multiple devices and expensive capital equipment.
By simplifying the workflow and minimizing device exchanges, iCHOR has the potential to reduce overall procedure time.
iCHOR offers a cost-effective alternative with a simplified approach, avoiding the cumulative costs associated with multiple disposables and adjunctive tools.
Advanced / In-Depth Questions
iCHOR is particularly effective in cases involving soft to subacute thrombus, including dialysis access declots, DVT, and peripheral arterial occlusions.
Yes. It can be used alongside thrombolytic therapy when clinically indicated to enhance clot removal.
While optimized for soft thrombus, iCHOR can be used in combination strategies for more organized clot, depending on physician technique and adjunctive therapies.
The learning curve is minimal, especially for physicians familiar with Fogarty balloon techniques.
The nitinol basket is engineered to provide effective clot capture while maintaining flexibility and trackability within the vasculature.
Adoption and Support
iCHOR provides hands-on training, case support and physician education programs to ensure successful adoption.
Yes. Clinical specialists are available to support physicians during early adoption and complex cases.
iCHOR’s simplified workflow and lower cost structure make it well-suited for both hospital and outpatient (ASC/OBL) settings.
Clinical workflow
Simpler tools can support faster decision-making, more consistent technique, and easier adoption in routine practice.
Safety, effectiveness, procedural control, ease of use, and how well the device fits existing workflow are common priorities.
Because effective clot removal must also minimize injury to the vessel wall and reduce complications.
It is important because avoiding downstream embolization can improve procedural confidence and patient safety.
Faster, more efficient procedures can improve operating room utilization, reduce resource strain, and support better economics.
